13F filer · CIK 1103804 ↗
Viking Global
You are looking at Q2 2019. See the latest, Q2 2026 →
Reported value
$22.29B
+28% on the quarter before
Positions
59
19 new · 17 sold out
Top 10
54.0%
of the value
Est. gain
+$402.3M
on stocks held all quarter
Est. return
+3.7%
on those stocks since Q1 2019
Positions as of Jun 30, 2019, from Viking Global's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q1 2019. Striped tiles are options.
Largest buys
Since Q1 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Adaptive Biotechnologies Cor~$1.86BNew · 0.0% → 8.3%+38,406,607 shares
- Boeing Co~$1.01BNew · 0.0% → 4.5%+2,777,120 shares
- Meta~$952.3MAdded · 2.0% → 6.1%+4,934,406 shares
- Amazon~$930.0MAdded · 3.2% → 6.8%+491,118 shares
- Bridgebio Pharma Inc~$718.0MNew · 0.0% → 3.2%+26,620,991 shares
- Uber~$620.0MNew · 0.0% → 2.8%+13,368,682 shares
- Jd Com Inc~$614.0MAdded · 2.0% → 4.3%+20,269,351 shares
- Monster Beverage Corp New~$565.0MNew · 0.0% → 2.5%+8,851,947 shares
- Centene Corp Del~$513.7MAdded · 1.3% → 3.3%+9,795,824 shares
- Salesforce~$443.4MNew · 0.0% → 2.0%+2,922,394 shares
Largest sells
Since Q1 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Alibaba~$872.6MCut · 6.0% → 0.4%−5,149,456 shares
- Marathon Pete Corp~$822.5MSold out · 4.7% → 0.0%−13,742,884 shares
- Visa Inc.~$466.4MCut · 2.8% → 0.3%−2,687,425 shares
- Thermo Fisher Scientific Inc~$313.7MSold out · 1.8% → 0.0%−1,146,037 shares
- Berry Global Group Inc~$311.2MCut · 2.4% → 0.4%−5,916,864 shares
- Anthem Inc~$281.3MCut · 10.2% → 6.6%−996,880 shares
- Microsoft~$277.3MCut · 6.6% → 4.6%−2,069,837 shares
- Wellcare Health Plans Inc~$270.5MCut · 2.0% → 0.5%−948,954 shares
- Adobe~$243.9MCut · 3.1% → 1.6%−827,919 shares
- Walt Disney Company (The)~$241.2MSold out · 1.4% → 0.0%−2,172,157 shares
Holdings
As of Jun 30, 2019. Changes are in shares against Mar 31, 2019, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Adaptive Biotechnologies CorCOM · shares New | 8.3% | $1.86B | — | ||||||||
| AmazonCOM · shares +158% · price +6.3% | 6.8% | $1.52B | +$35.2M | ||||||||
| Anthem IncCOM · shares −16% · price −1.7% | 6.6% | $1.47B | −$24.8M | ||||||||
| MetaCL A · shares +232% · price +15.8% | 6.1% | $1.36B | +$56.0M | ||||||||
| Unitedhealth Group IncCOM · shares +29% · price −1.3% | 5.3% | $1.17B | −$12.2M | ||||||||
| MicrosoftCOM · shares −21% · price +13.6% | 4.6% | $1.03B | +$123.4M | ||||||||
| Boeing CoCOM · shares New | 4.5% | $1.01B | — | ||||||||
| Jd Com IncSPON ADR CL A · shares +175% · price +0.5% | 4.3% | $963.9M | +$1.6M | ||||||||
| United Technologies CorpCOM · shares −4.8% · price +1.0% | 3.9% | $878.1M | +$8.8M | ||||||||
| NetflixCOM · shares +3.4% · price +3.0% | 3.4% | $759.5M | +$21.5M | ||||||||
| Centene Corp DelCOM · shares +233% · price −1.2% | 3.3% | $733.9M | −$2.8M | ||||||||
| Bridgebio Pharma IncCOM · shares New | 3.2% | $718.0M | — | ||||||||
| UberCOM · shares New | 2.8% | $620.0M | — | ||||||||
| Monster Beverage Corp NewCOM · shares New | 2.5% | $565.0M | — | ||||||||
| MercadoLibreCOM · shares +40% · price +20.5% | 2.3% | $523.0M | +$63.7M | ||||||||
| Illumina IncCOM · shares +16% · price +18.5% | 2.3% | $504.8M | +$67.9M | ||||||||
| SalesforceCOM · shares New | 2.0% | $443.4M | — | ||||||||
| Liberty Media Corp DelawareCOM SER C FRMLA · shares −2.5% · price +6.7% | 1.9% | $425.7M | +$26.9M | ||||||||
| Boston Scientific CorpCOM · shares +186% · price +12.0% | 1.8% | $395.2M | +$14.8M | ||||||||
| Activision Blizzard IncCOM · shares +61% · price +3.7% | 1.7% | $373.3M | +$8.2M | ||||||||
| AdobeCOM · shares −41% · price +10.6% | 1.6% | $357.8M | +$34.2M | ||||||||
| Align Technology IncCOM · shares −35% · price −3.7% | 1.4% | $317.8M | −$12.3M | ||||||||
| AlphabetCAP STK CL A · shares −25% · price −8.0% | 1.4% | $305.5M | −$26.5M | ||||||||
| Exact Sciences CorpCOM · shares −30% · price +36.3% | 1.2% | $267.3M | +$71.2M | ||||||||
| MicronCOM · shares +181% · price −6.6% | 1.1% | $248.2M | −$6.3M | ||||||||
| Total · 59 positions | 100% | $22.29B | +$402.3M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2019 to Q2 2019: 40 stocks held throughout, up $402.3M (+3.7%).
- Microsoft+$123.4M+14%
- Exact Sciences Corp+$71.2M+36%
- Illumina Inc+$67.9M+18%
- MercadoLibre+$63.7M+20%
- Meta+$56.0M+16%
- Anaptysbio Inc−$13.3M−23%
- Anthem Inc−$24.8M−2%
- Covetrus Inc−$25.0M−23%
- Alphabet−$26.5M−8%
- Moderna Inc−$46.8M−28%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $35.08B−2% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $35.75B−5% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $37.68B−2% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $38.50B+11% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $34.59B+10% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $31.48B+2% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $30.90B+13% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $27.44B+5% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $26.02B−3% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $26.86B−2% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $27.30B+11% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $24.64B+1% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $24.43B+15% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $21.31B+7% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $19.98B−8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $21.66B−1% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $21.86B−12% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $24.74B−29% | SEC ↗ |
| Q4 2021 | May 16, 2022 (amended) | $34.71B−5% | SEC ↗ |
| Q3 2021 | May 16, 2022 (amended) | $36.46B+11% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $32.98B−2% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $33.58B−8% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $36.37B+31% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $27.68B+20% | SEC ↗ |
| Q2 2020 | Aug 7, 2020 | $23.14B+20% | SEC ↗ |
| Q1 2020 | May 13, 2020 | $19.21B−10% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $21.35B+11% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $19.20B−14% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $22.29B+28% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $17.44B−1% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $17.57B−3% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $18.06B+3% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $17.47B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $16.61B+2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $16.26B+5% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $15.44B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $14.85B−34% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $22.64B+3% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $22.01B−5% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $23.18B−2% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $23.54B+4% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $22.72B | SEC ↗ |